The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS
Abstract
PURPOSE: Teratoma with malignant transformation refers to a form of germ cell tumor in which a somatic teratomatous component becomes morphologically malignant and develops aggressive growth. We evaluated the spectrum of histologies, chromosomal abnormalities and clinical outcome in patients with teratoma with malignant transformation. MATERIALS AND METHODS: We identified 46 patients with germ cell tumor meeting morphologic criteria for malignant transformation. Histology, disease extent and treatment were correlated with survival. Tumors in 12 patients were studied by conventional cytogenetics or molecular genetic techniques for the isochromosome 12p [i(12p)], a marker for germ cell tumor, as well as other chromosomal abnormalities. RESULTS: The site of first detection of malignant transformation occurred in the primary tumor of 21 cases (44%), at a metastatic site in 20 (43%) and in both sites in 5 (10%). Sarcoma was the most frequent histology, identified in 29 patients (63%) with rhabdomyosarcoma the most common subtype. Seventeen tumors (37%) contained a solid tumor histology other than sarcoma, with adenocarcinoma and primitive neuroectodermal tumor as the most common histologies. Four patients with mediastinal germ cell tumor containing sarcoma also had hematological malignancies, including a focus of nonHodgkin's lymphoma in the mediastinal primary tumor (1) and nonlymphocytic leukemia in spleen or bone marrow (3). Patients who had teratoma with malignant transformation components confined to the testis or retroperitoneum completely resected experienced a longer survival than those with distant metastases or incompletely resected tumors (p = 0.003). Chromosomal abnormalities associated with germ cell tumor (i[12p]) were identified in 11 of 12 tumors containing adenocarcinoma, primitive neuroectodermal tumor, sarcoma and leukemia. In addition to i (12p), chromosomal rearrangements characteristic of the transformed histology were detected in 4 tumors. CONCLUSIONS: A variety of nongerm cell histologies, including sarcoma, adenocarcinoma, primitive neuroectodermal tumor and leukemia, may occur in association with germ cell tumor. Chromosomal abnormalities in these tumors include i (12p), reflecting germ cell tumor clonality, as well as chromosomal abnormalities associated with the transformed histology. These tumors do not respond like germ cell tumor to cisplatin-containing chemotherapy regimens. Treatment should be tailored according to that used in standard management of the transformed histology, and surgical resection is the mainstay of therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Catalog of chromosome aberrations in cancer
Mitelman, F. (1985) · Medical Entomology and Zoology · Cited by 1,503
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., & Rowley, J. D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.325 · Cited by 671
Logothetis, C. J., Samuels, M. L., Trindade, A., & Johnson, D. E. (1982) · Cancer · doi:10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1 · Cited by 552
Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors
Nichols, C. R., Roth, B. J., Heerema, N. A., Griep, J. A., & Tricot, G. J. K. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222004 · Cited by 335
Catalog of Chromosome Aberrations in Cancer
Secker-Walker, L. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.223 · Cited by 211
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Bosl, G. J., Gluckman, R., Geller, N. L., Golbey, R. B., Whitmore, W. F., Herr, H., Sogani, P., Morse, M., Martini, N., & Bains, M. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1493 · Cited by 198
Self-citationKushner, B. H., Meyers, P. A., Gerald, W. L., Healey, J. H., La Quaglia, M. P., Boland, P., Wollner, N., Casper, E. S., Aledo, A., & Heller, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2796 · Cited by 163
Ladanyi, M., Samaniego, F., Reuter, V. E., Motzer, R. J., Jhanwar, S. C., Bosl, G. J., & Chaganti, R. S. K. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.3.221 · Cited by 149
Self-citation
Cited by
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act
Lubberts, S., Meijer, C., Demaria, M., & Gietema, J. A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102963 · Cited by 19
Metadata
- Authors
- Motzer, R. J., Amsterdam, A., Prieto, V., Sheinfeld, J., Murty, V. V. V. S., Mazumdar, M., Bosl, G. J., Chaganti, R. S. K., & Reuter, V. E.
- Venue
- Journal of Urology
- Published
- 1998-01
- Volume
- 159
- Issue
- 1
- Pages
- 133-138
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2026102604
- Cited by
- 431
- References
- 11
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS. https://app.cochat.ai/papers/10.1016/s0022-5347(01)64035-7
- The paper
- Motzer, R. J., Amsterdam, A., Prieto, V., Sheinfeld, J., Murty, V. V. V. S., Mazumdar, M., Bosl, G. J., Chaganti, R. S. K., & Reuter, V. E. (1998). TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)64035-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.